You have 9 free searches left this month | for more free features.

Diabetes Mellitus, Non-Insulin-Dependent

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Non-Insulin-Dependent Trial (sulforaphane, Placebo)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • (no location specified)
Jan 14, 2022

Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Technology Intensified)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +4 more
  • Technology Intensified
  • Charleston, South Carolina
    Medical University of South Carolina
Apr 4, 2022

Diabetes, Diabete Type 2 Trial in Reno (Dayamed Arthur a novel intelligent medication adherence platform)

Completed
  • Diabetes
  • Diabete Type 2
  • Dayamed Arthur a novel intelligent medication adherence platform
  • Reno, Nevada
    VA Sierra Nevada Health Care System
Mar 15, 2023

Diabetes, Type 2 Trial (Intermittently scanned continuous glucose monitor (isCGM), Education and individualized feedback)

Recruiting
  • Diabetes Mellitus, Type 2
  • Intermittently scanned continuous glucose monitor (isCGM)
  • Education and coaching
  • Edmonton, Alberta, Canada
    University of Alberta Hospital / Kaye Edmonton Clinic
Oct 6, 2022

Weight Loss, Metabolic Syndrome, Diabetes, Type 2 Trial in Palo Alto (Continuous Glucose Monitor Device)

Recruiting
  • Weight Loss
  • +6 more
  • Continuous Glucose Monitor Device
  • Palo Alto, California
    Signos
May 24, 2023

Diabetes, Non Insulin Dependent Diabetes Trial in New York (Telehealth Bridge Visits, Standard of Care)

Not yet recruiting
  • Diabetes Mellitus
  • Non Insulin Dependent Diabetes Mellitus
  • Telehealth Bridge Visits
  • Standard of Care
  • New York, New York
    NYU Langone Health
Jun 2, 2023

Diabetes, Non-Insulin-Dependent, Hypertriglyceridemia Trial in Baton Rouge (Metformin Eicosapentaenoate, Metformin HCl and

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Hypertriglyceridemia
  • Metformin Eicosapentaenoate
  • Metformin HCl and Vascepa
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Apr 25, 2022

Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))

Completed
  • Type 2 Diabetes Mellitus
  • Postprandial Hyperglycemia
  • Insulin aspart (Novorapid®)
  • Stockholm, Sweden
    Department of Medicine, Clinical pharmacology Unit, Karolinska U
May 24, 2022

Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:

Completed
  • Type 2 Diabetes
  • Nephropathy
  • MK0954, losartan / Duration of Treatment: mean 3.4 years
  • Placebo / Duration of Treatment: mean 3.4 years
  • (no location specified)
Feb 7, 2022

Diabetes, Type 2, Diabetes, Adult-Onset, Diabetes, Non-Insulin-Dependent Trial in Charleston (Diabetes Knowledge/Information,

Completed
  • Diabetes Mellitus, Type 2
  • +4 more
  • Diabetes Knowledge/Information
  • +3 more
  • Charleston, South Carolina
    Medical University of South Carolina
Jun 16, 2021

Type 2 Diabetes Trial in Aurora (Acipimox, Placebo)

Completed
  • Type 2 Diabetes
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Nov 5, 2021

Diabetes, Type 2 Diabetes, Adult-Onset Diabetes Trial in Milwaukee (High Frequency Financial Incentive, Moderate Frequency

Completed
  • Diabetes Mellitus
  • +4 more
  • High Frequency Financial Incentive
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Oct 7, 2021

ERAS, Surgery, Non Insulin Dependent Diabetes Trial in Alexandria (ERAS protocol)

Recruiting
  • ERAS
  • +3 more
  • ERAS protocol
  • Alexandria, Egypt
    Faculty of Medicine, Alexandria University
Sep 5, 2021

Diabetes, Non-Insulin-Dependent, Hypertensive Disease Trial in New Orleans (Liraglutide or Placebo)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Hypertensive Disease
  • Liraglutide or Placebo
  • New Orleans, Louisiana
    Tulane University Health Science Center, Tidewater building and
Jan 6, 2021

Diabetes Trial in Shanghai (Autologous regenerative islet transplantation for insulin-dependent diabetes mellitus)

Recruiting
  • Diabetes
  • Autologous regenerative islet transplantation for insulin-dependent diabetes mellitus
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 15, 2022

Hyperlipidemia, Diabetes, Type 2, Non-Insulin Dependent Diabetes Trial in Germany (Atorvastatin, Placebo)

Terminated
  • Hyperlipidemia
  • +2 more
  • BAD Muenster AM Stein, Germany
  • +13 more
Feb 17, 2021

Type 1 Diabetes, Type 2 Diabetes Treated With Insulin Trial in Seongnam (Intervention by medical staff based on a cloud system)

Completed
  • Type 1 Diabetes Mellitus
  • Intervention by medical staff based on a cloud system
  • Seongnam, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Oct 22, 2022

Telemedicine, Insulin Dependent Diabetes 1 Trial in Aabenraa (Intervention group video consultations)

Recruiting
  • Telemedicine
  • Insulin Dependent Diabetes Mellitus 1
  • Intervention group video consultations
  • Aabenraa, Denmark
    Sygehus Soenderjylland
Aug 30, 2022

Insulin Dependent Diabetes, Diabetes type2 Trial in Sirnak

Completed
  • Insulin Dependent Diabetes
  • Diabetes type2
    • Şirnak, Merkez, Turkey
      Şirnak Devlet Hastanesi
    Jun 22, 2023

    Diabetes, Non-Insulin-Dependent, Erectile Dysfunction Trial in Amiens (DE assessment, AGE measurement)

    Completed
    • Diabetes Mellitus, Non-Insulin-Dependent
    • Erectile Dysfunction
    • DE assessment
    • AGE measurement
    • Amiens, France
      CHU Amiens
    Jul 17, 2020

    Diabetes, Type 2, Insulin Dependent Diabetes Trial in Chicago (DM Discharge Toolkit)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Insulin Dependent Diabetes
    • DM Discharge Toolkit
    • Chicago, Illinois
      Northwestern Memorial Hospital
    Jan 31, 2023

    Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)

    Not yet recruiting
    • Type 2 Diabetes
    • NAFLD
    • Drinking powder supplement
    • (no location specified)
    Dec 8, 2022

    Type 1 Diabetes Trial in Trondheim (Glucagon)

    Recruiting
    • Type 1 Diabetes
    • Trondheim, Norway
      Department of Endocrinology, St. Olavs Hospital
    Jul 17, 2023

    Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Multiple Dose Insulin Therapy
    • Personalized treatment
    • (no location specified)
    Nov 18, 2023

    Diabetes, Type 2, Insulin Resistance, Diabetes Trial in Cairo (High intensity interval training, moderate intensity aerobic

    Recruiting
    • Diabetes Mellitus, Type 2
    • Insulin Resistance, Diabetes
    • High intensity interval training
    • moderate intensity aerobic exercise
    • Cairo, Egypt
    • +3 more
    Jun 3, 2023